Baker Hughes is downgraded from Buy to Watchlist. The investment score falls from 68.2 to 63.9. The previous report, published on 31 August at $62.41, carried a $59.00 cut-loss and argued explicitly against widening it. On 11 September the shares closed at $59.06, six cents above that level, having traded as low as $57.24 during the session.

Why did a guidance raise take 7% out of the stock? On 9 September the company lifted 2026 revenue guidance to $28.50bn to $30.30bn from $26.65bn to $28.05bn, and adjusted EBITDA to $4.88bn to $5.48bn from $4.6bn to $5.1bn. Both midpoints sit above consensus. What accompanied the raise did the damage. Free cash flow conversion for the year was cut to 40% to 45%, with management attributing the entire shortfall to acquisition-related costs: cash interest, transaction expense and integration spending. Chart Industries was set at roughly 17% margin in the second half, below what the sell side had modelled, reaching 22% to 23% only by the second half of 2028. And 55% to 65% of the segment’s 2026 EBITDA was placed in the fourth quarter.

Has the investment case broken? Not on the terms the previous report named. Industrial and Energy Technology margin, flagged in August as the single biggest thing to watch, is now guided above 20% for the year against a record 18.3% in the second quarter. Data centre power orders, flagged as the thing that would invalidate the thesis, reached $3.2bn in the first half and $4.2bn since 2025. The backlog restatement disclosed alongside the update was a methodology alignment, and the commitment to more than $45bn of Horizon Two orders was reaffirmed rather than trimmed.

So what actually changed? The cash. A 5.1% free cash flow yield was the least assumption-dependent support under this valuation, and on the company’s own reduced conversion guidance it now computes nearer 3.75%. Management’s framing that the shortfall is non-recurring is probably right, but it remains a framing until a quarter demonstrates it, and more than half of Chart’s annual contribution now depends on a quarter that has not started.

Two routes lead back to Buy. Below $55 the shares offer about 4.0% of free cash flow on the reduced guidance and roughly 19.5 times the forward estimate, a wide enough margin to absorb a slipped quarter. Alternatively, a reclaim of the $60.44 fifty-day average after third-quarter results on 22 October, with the fourth-quarter ramp visibly beginning.

The full valuation work, risk register and scenario analysis sit in the complete Baker Hughes (BKR) report on our Reports page.